Sign In
Buy LGND
$234.40
+1.64 (+0.705%)
At Close: Jun 03, 2026
7 Small-Cap Stocks for the Thinking Speculator
02:46pm, Monday, 08'th Apr 2024
It may sound counterintuitive but if you want big gains, you have to think small, as in small-cap stocks. Here, the idea is to trade predictability for maximum profit potential.
LONDON--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partners at the University of Minnesota (UMN) and CURx Pharmaceuticals, Inc. presented new data on
Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts
07:06pm, Friday, 05'th Apr 2024
Ligand Pharmaceuticals (LGND) closed at $77.96 in the latest trading session, marking a -0.03% move from the prior day.
Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It?
10:36am, Thursday, 04'th Apr 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Investors Heavily Search Ligand Pharmaceuticals Incorporated (LGND): Here is What You Need to Know
10:05am, Thursday, 04'th Apr 2024
Zacks.com users have recently been watching Ligand (LGND) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
09:00am, Wednesday, 03'rd Apr 2024
JUPITER, Fla. & DURHAM, N.C.--(BUSINESS WIRE)--Ligand Pharmaceuticals (Nasdaq: LGND) today announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of s
Ligand Pharmaceuticals (LGND) Ascends While Market Falls: Some Facts to Note
07:20pm, Monday, 01'st Apr 2024
In the latest trading session, Ligand Pharmaceuticals (LGND) closed at $73.60, marking a +0.68% move from the previous day.
Ligand Pharmaceuticals (LGND) Falls More Steeply Than Broader Market: What Investors Need to Know
07:21pm, Tuesday, 26'th Mar 2024
In the most recent trading session, Ligand Pharmaceuticals (LGND) closed at $68.64, indicating a -0.88% shift from the previous trading day.
Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock
10:01am, Thursday, 21'st Mar 2024
Zacks.com users have recently been watching Ligand (LGND) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
07:06pm, Wednesday, 20'th Mar 2024
In the most recent trading session, Ligand Pharmaceuticals (LGND) closed at $73.11, indicating a +1.25% shift from the previous trading day.
Ligand (LGND) Is Considered a Good Investment by Brokers: Is That True?
10:31am, Tuesday, 19'th Mar 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for Investors
07:06pm, Thursday, 14'th Mar 2024
Ligand Pharmaceuticals (LGND) reachead $71.93 at the closing of the latest trading day, reflecting a -1.14% change compared to its last close.
Is Trending Stock Ligand Pharmaceuticals Incorporated (LGND) a Buy Now?
10:01am, Thursday, 07'th Mar 2024
Ligand (LGND) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street Analysts See Ligand (LGND) as a Buy: Should You Invest?
10:30am, Thursday, 29'th Feb 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges
08:36am, Wednesday, 28'th Feb 2024
Ligand Pharmaceuticals (LGND) reports encouraging fourth-quarter results as earnings and sales beat estimates. Management reiterates the 2024 financial outlook.
